A randomized, Open-Label, Parallel, Multi-Center Phase IV Study to Compare the Efficacy and Safety of Atorvastatin 10 and 20 mg in HighRisk Asian Patients with Hypercholesterolemia
ViewEffect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus (T2DM)
ViewEfficacy of oral rosuvastatin intervention on high density lipoproteins (HDL) and its associated proteins in men with type 2 diabetes mellitus (T2DM)
ViewAzithromycin for sarcoidosis cough: an open-label exploratory clinical trial
ViewClinical Utilization Pattern of Multiple Strengths of Glimepiride and Metformin Fixed Dose Combinations (FDC) in Indian Type 2 Diabetes Patients
ViewEffectiveness of Atorvastatin in the Treatment of Asymptomatic Heart Failure after Myocardial Infarction: A Clinical Study
ViewEfficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
ViewGlimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
ViewAtorvastatin Reduces First and Subsequent Vascular Events across Vascular Territories (cerebrovascular, coronary, or peripheral): The SPARCL Trial
ViewReal-World Observational Study of Glimepiride and Metformin FixedDose Combination (FDC) Along With Insulin in the Management of Type 2 Diabetes Mellitus (T2DM): Indian Experience
View